UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000044354
Receipt No. R000050656
Scientific Title The Efficacy of Transcatheter Arterial Micro-Embolization for Synovitis after Total Knee Arthroplasty
Date of disclosure of the study information 2021/06/01
Last modified on 2021/05/28 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The Efficacy of Transcatheter Arterial Micro-Embolization for Synovitis after Total Knee Arthroplasty
Acronym The Efficacy of Transcatheter Arterial Micro-Embolization for Synovitis after Total Knee Arthroplasty
Scientific Title The Efficacy of Transcatheter Arterial Micro-Embolization for Synovitis after Total Knee Arthroplasty
Scientific Title:Acronym The Efficacy of Transcatheter Arterial Micro-Embolization for Synovitis after Total Knee Arthroplasty
Region
Japan

Condition
Condition Chronic post-surgical pain after total knee arthroplasty
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Although total knee arthroplasty (TKA) is an effective treatment for osteoarthritis (OA), postoperative persistent pain may occur and patient satisfaction may be compromised. We have evaluated post-TKA synovitis (total PD score) using the power Doppler method (PD) of the ultrasonography (US), and have found that post-TKA persistent pain is related to the total PD score. post-TKA synovitis is considered to be a new cause of post-TKA persistent pain, and the development of a treatment method is urgently needed.
The purpose of this study is to provide a pilot single-arm prospective study of transcatheter arterial micro-embolization (TAME) in patients with persistent pain and to gain a foothold for the treatment of post-TKA synovitis with TAME.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes pain VAS during walking after 6 months of TAME
Key secondary outcomes Pain VAS at 3, 6, and 12 months after TAME, WOMAC score, assessment of pain and function at 3, 6, and 12 months using the WOMAC score, and assessment of the number and type of adverse events from TAME to the 12-month assessment

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 transcatheter arterial micro-embolization (TAME)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
50 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Patients with post-TKA prolonged pain (pain VAS 30 or more) who have received conservative therapy for 3 months and have prolonged pain due to post-TKA synovitis.
Key exclusion criteria Patients who meet the following criteria: no other conditions that cause pain, no anticoagulant medication, synovitis confirmed by ultrasound, and no problems with surgery on preoperative examination.
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Natsuki
Middle name
Last name Sugimura
Organization Department of Orthopaedics, Kochi University
Division name Orthopaedics surgery
Zip code 783-8505
Address 185-1 Kohasu, Okochom, Nankoku, Kochi, Japan
TEL 0888802386
Email sugimura.n@kochi-u.ac.jp

Public contact
Name of contact person
1st name Natsuki
Middle name SUGIMURA
Last name Sugimura
Organization Kochi university
Division name Department orthopaedics surgery
Zip code 783-8505
Address 185-1 Oko-cho Kohasu
TEL 0888802386
Homepage URL
Email sugimura.n@kochi-u.ac.jp

Sponsor
Institute Kochi University
Institute
Department

Funding Source
Organization Japan Science and Technology Agency
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kochi university
Address Nankoku
Tel 0888802386
Email sugimura.n@kochi-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 06 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 06 Month 15 Day
Date of IRB
Anticipated trial start date
2021 Year 08 Month 01 Day
Last follow-up date
2025 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 05 Month 28 Day
Last modified on
2021 Year 05 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050656